SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
193 hedge funds and large institutions have $657M invested in SANGAMO THERAPEUTICS INC in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 56 increasing their positions, 56 reducing their positions, and 18 closing their positions.
78% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 18
5% more funds holding
Funds holding: 184 → 193 (+9)
0% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 56
3.29% less ownership
Funds ownership: 70.98% → 67.7% (-3.3%)
12% less capital invested
Capital invested by funds: $744M → $657M (-$87.2M)
21% less call options, than puts
Call options by funds: $10.5M | Put options by funds: $13.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$6.58M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$5.41M |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$3.68M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.48M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$28.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$11.3M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$9.2M |
| 4 |
Jennison Associates
New York
|
-$4.67M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.88M |
SGMO Hedge Fund Activity: Q4 2019 in Review
193 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2019, worth a combined $657M — down 12% from $744M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new SGMO positions and 18 closed out — a net gain of 14 holders — while 56 added to existing stakes and 56 trimmed.
The largest buyer was Pictet Asset Management (UK), adding an estimated $6.58M. The largest seller was Wellington Management Group, cutting an estimated $28.8M.
- 193 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2019, up from 184 in Q3 2019.
- Funds reported $657M of SANGAMO THERAPEUTICS INC stock for Q4 2019, down 12% quarter-over-quarter.
- 32 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2019 and 18 closed out, a net change of +14 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q4 2019 was Pictet Asset Management (UK), an estimated $6.58M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q4 2019 was Wellington Management Group, an estimated $28.8M sold.
Based on aggregated 13F filings for Q4 2019.